Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index; none of the 76 sources its claims cite is checked for support yet.

Scale up manufacturing approach for production of human induced pluripotent stem cell-derived islets using Vertical Wheel® bioreactors

Open access
Dadheech, Nidheesh, Bermúdez de León, Mario, Czarnecka, Zofia, Cuesta-Gomez, Nerea, Jasra, Ila Tewari, Pawlick, Rena, Marfil-Garza, Braulio, Sapkota, Sandhya, Verhoeff, Kevin, Razavy, Haide, Anwar, Perveen, Singh, Abhineet, Ray, Nilanjan, O’ Gorman, Doug, Jickling, Glen, Lyon, James, MacDonald, Patrick, Shapiro, A. M. James·2025·npj Regenerative Medicine

Abstract

Advanced protocols show potential for human stem cells (SC)-derived islets generation under planar (2D) alone or three-dimensional (3D) cultures, but show challenges in scalability, cell loss, and batch-to-batch consistency. This study explores Vertical Wheel (VW)® bioreactor suspension technology to differentiate islets from human induced pluripotent stem cells, achieving uniform, transcriptionally mature, and functional SC-islets. A 5x increase in scale from 0.1 L to 0.5 L reactors resulted in a 12-fold (15,005–183,002) increase in islet equivalent count (IEQ) without compromising islet structure. SC-islets show enriched β-cell composition (~63% CPPT + NKX6.1 + ISL1 + ), glucose responsive insulin release (3.9–6.1-fold increase), and reversed diabetes in STZ-treated mice. Single cell RNA sequencing and flowcytometry analysis confirmed transcriptional maturity and functional identity, similar to adult islets. Lastly, harvested SC-islet grafts demonstrate improved islet functionality and mature transcriptomic signatures. Overall, scale-up in VW® bioreactor technology enhances IEQ yield with minimal variability and reduced cell loss, offering a pathway for clinical-grade SC-islet production.

Overview

CoChat Summary

TL;DR

A modified 27-day, full-suspension differentiation protocol using Vertical Wheel® bioreactors generated human iPSC-derived islets that were transcriptionally and functionally islet-like and reversed diabetes in mice. A 5× vessel scale-up from 0.1 L to 0.5 L increased islet equivalent yield 12-fold without compromising islet structure.

Key findings

  • Scale-up from 0.1 L to 0.5 L VW® bioreactors gave a 2.1 ± 0.09-fold increase in SC-islet clusters and a 12.2 ± 1.6-fold increase in IEQ (15,005 IEQ in 0.1 L vs 183,002 IEQ in 0.5 L), with linear S6 cell production (0.39 vs 0.41 million S6 cells per million iPSCs).
  • S6w1 islets showed endocrine composition: 88.1 ± 1.8% CPPT+, 51.8 ± 2.3% CPPT+NKX6.1+, 43.6 ± 1.8% CPPT+ISL1+, 48.06 ± 0.6% INS+, 35.53 ± 0.8% GCG+, and 10.39 ± 1% SST+ cells; off-target Ki67+ was 2.23 ± 0.5%, Oct4+/Ki67+ 0.33 ± 0.1%, and CDX2+/Ki67+ 1.9 ± 0.3%.
  • S6w1 islets were glucose-responsive in vitro, with a 3.9–6.1-fold increase in insulin release and static secretion of 4.9 ± 1.2 µIU/ml at high glucose vs 0.9 ± 0.2 µIU/ml at low glucose per 1000 cells; dynamic perifusion showed a peak of 6.6 ± 0.2-fold over G3.
  • In STZ-diabetic SCID-beige mice, >50% of transplanted mice achieved euglycemia within 30 days and all 15 transplanted mice showed diabetes reversal by 60 days; stimulated human C-peptide increased from 0.8 ± 0.08-fold at 8 weeks to 3.10 ± 0.49-fold at 16 weeks. scRNAseq showed islet-like populations comparable to adult islets but with a fetal-like maturation phenotype.

Methods

  • Three human iPSC lines from healthy, total pancreatectomy, and type 1 diabetes donors were expanded and differentiated in 0.1 L or 0.5 L PBS mini-Vertical Wheel® bioreactors using a six-stage, 27-day suspension protocol modified from Sui et al., with aphidicolin added during Stage 6.
  • Characterization included brightfield/dithizone imaging, immunohistochemistry, flow cytometry, dynamic and static GSIS, TaqMan low-density array gene expression, and scRNA-seq with Seurat/Azimuth projection against human pancreas and donor islet datasets.
  • In vivo testing transplanted 2500 IEQ S6w1 SC-islets under the kidney capsule of STZ-induced diabetic immunodeficient SCID-beige mice; grafts were assessed by blood glucose, IPGTT, human C-peptide, histology, flow cytometry, and gene expression up to 16 weeks.

Limitations

  • The paper states that S6w1 islets remain immature with a fetal-like phenotype, show lower in vitro insulin release than adult islets, and require months of in vivo maturation; the protocol was equivalent but not superior to published protocols for in vitro functionality and maturation.
  • The paper notes that aphidicolin may inhibit DNA polymerases and impair DNA repair, potentially affecting genomic stability, and suggests exploring less toxic cell-cycle inhibitors such as PD166167 and ZM426012.
  • Evident from the text: randomization was not performed, although analysis was blinded; some animal groups were small (e.g., n = 4 diabetic controls, n = 15 transplanted), and long-term human clinical safety/efficacy is not established.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41536-025-00409-y

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Scale-up potential of Vertical Wheel® bioreactors in the generation of human pancreatic islets from induced pluripotent stem cells. a Overview seed-train of 27-day six-stage suspension culture differentiation protocol using VW® bioreactors with quality control release parameters and stage-specific growth factors added to each stage. Created in BioRender. Dadheech, N. (2025) https://BioRender.com/u86j668. Stages 1–7 termed as S1: definitive endoderm, S2: primitive gut tube, S3: posterior foregut, S4: pancreatic progenitors, S5: endocrine progenitors, S6: SC-islets. b Phase contrast and brightfield images of SC-islets for morphology and dithizone staining (red) to confirm islet differentiation. Scale bars, 250 µm. c Quantification, and size distribution of SC-islet clusters generated from 0.1 L and 0.5 L bioreactor vessels. Unpaired parametric t-test was performed with 95% confidence interval. All data are presented as median (IQR-27–75%), n = 190–210. d Violin plot representing average generation S6 cell as percentage of initial cell mass between 0.1 L and scale-up 0.5 L volumes. One-way analysis of variance (ANOVA), multiple comparison using Turkey correction with 95% confidence interval. All data are presented as mean ± sem, n = 11–13 pooled differentiation batches generated using three iPSC lines from healthy, total pancreatectomy, and type-1 diabetes donors (3–4 batches per line), p value statistically non-significant. e Box plot to show SC-islet production index-million S6 cells differentiation per million iPSCs between 0.1 L and scale-up 0.5 L volumes. One-way analysis of variance (ANOVA), multiple comparison using Turkey correction with 95% confidence interval. All data are presented as mean ± sem, n = 4–8 pooled differentiation batches generated using healthy, total pancreatectomy, and type-1 diabetes donor iPSC lines, p value statistically non-significant. f Graphical representation to show violin plot quantification (left axis) for total number of SC-islet cluster generation and (right axis) corresponding islet equivalent count measurements between 0.1 L and 0.5 L vessels. Two-way ANOVA with multiple comparison statistical method was used adopting Šidák correction with 95% confidence interval. All data are presented as mean ± sem, n = 4–5 pooled differentiation batches generated using healthy, total pancreatectomy, and type-1 diabetes donor iPSC lines. *p < 0.05 and ****p < 0.0001. g Immunohistochemistry of day 27 harvested SC-islets from a health iPSC line probed with endocrine cell and pluripotency markers. Scale bars, 50 µm. h Violin plot representing quantification to measure the efficient for absolute SC-β cell generation within 0.1 L and scale-up 0.5 L bioreactor vessel. i Representative flow cytometry plots (left) marking islet cells in S6w1 SC-islets for markers- Insulin, Glucagon, Somatostatin, MafA, C-peptide, NKX6.1, and ISL1. Quantification graphs (right) show percentage cell count for Insulin, Glucagon, MAFA, Somatostatin, C-peptide, and NKX6.1 in S6w1 SC-islets. One-way analysis of variance (ANOVA), multiple comparison using Turkey correction with 95% confidence interval. All data are presented as mean ± sem, n = 4-5 pooled differentiation batches generated using healthy, total pancreatectomy, and type-1 diabetes donor iPSC lines. *p < 0.05 and ****p < 0.0001. j Representative flow cytometry plots and quantification for enterochromaffin cell generation within the SC-β cells in S6w1 clusters. Multiple ttest statistical method is used to compare two variables with 95% confidence interval. All data are presented as mean ± sem, n = 4 pooled differentiation batches generated using healthy, total pancreatectomy, and type-1 diabetes donor iPSC lines. ****p < 0.0001. Immunohistology image show staining for SC-EC marker-SLC18A1 co-labeling with insulin. Scale bars, 50 µm. k Representative flow cytometry plots (left) to show absolute cell composition for off-target population in S6w1 SC-islets. Violin plot (right) show quantification of percentage off-target cells generated in comparison to isotype control. Two-way ANOVA with multiple comparison statistical method is used with Šidák correction and 95% confidence interval. All data are presented as mean ± sem, n = 3–4 pooled differentiation batches generated using healthy, total pancreatectomy, and type-1 diabetes donor iPSC lines. ****p < 0.0001.
Fig. 1 Scale-up potential of Vertical Wheel® bioreactors in the generation of human pancreatic islets from induced pluripotent stem cells. a Overview seed-train of 27-day six-stage suspension culture differentiation protocol using VW® bioreactors with quality control release parameters and stage-specific growth factors added to each stage. Created in BioRender. Dadheech, N. (2025) https://BioRender.com/u86j668. Stages 1–7 termed as S1: definitive endoderm, S2: primitive gut tube, S3: posterior foregut, S4: pancreatic progenitors, S5: endocrine progenitors, S6: SC-islets. b Phase contrast and brightfield images of SC-islets for morphology and dithizone staining (red) to confirm islet differentiation. Scale bars, 250 µm. c Quantification, and size distribution of SC-islet clusters generated from 0.1 L and 0.5 L bioreactor vessels. Unpaired parametric t-test was performed with 95% confidence interval. All data are presented as median (IQR-27–75%), n = 190–210. d Violin plot representing average generation S6 cell as percentage of initial cell mass between 0.1 L and scale-up 0.5 L volumes. One-way analysis of variance (ANOVA), multiple comparison using Turkey correction with 95% confidence interval. All data are presented as mean ± sem, n = 11–13 pooled differentiation batches generated using three iPSC lines from healthy, total pancreatectomy, and type-1 diabetes donors (3–4 batches per line), p value statistically non-significant. e Box plot to show SC-islet production index-million S6 cells differentiation per million iPSCs between 0.1 L and scale-up 0.5 L volumes. One-way analysis of variance (ANOVA), multiple comparison using Turkey correction with 95% confidence interval. All data are presented as mean ± sem, n = 4–8 pooled differentiation batches generated using healthy, total pancreatectomy, and type-1 diabetes donor iPSC lines, p value statistically non-significant. f Graphical representation to show violin plot quantification (left axis) for total number of SC-islet cluster generation and (right axis) corresponding islet equivalent count measurements between 0.1 L and 0.5 L vessels. Two-way ANOVA with multiple comparison statistical method was used adopting Šidák correction with 95% confidence interval. All data are presented as mean ± sem, n = 4–5 pooled differentiation batches generated using healthy, total pancreatectomy, and type-1 diabetes donor iPSC lines. *p < 0.05 and ****p < 0.0001. g Immunohistochemistry of day 27 harvested SC-islets from a health iPSC line probed with endocrine cell and pluripotency markers. Scale bars, 50 µm. h Violin plot representing quantification to measure the efficient for absolute SC-β cell generation within 0.1 L and scale-up 0.5 L bioreactor vessel. i Representative flow cytometry plots (left) marking islet cells in S6w1 SC-islets for markers- Insulin, Glucagon, Somatostatin, MafA, C-peptide, NKX6.1, and ISL1. Quantification graphs (right) show percentage cell count for Insulin, Glucagon, MAFA, Somatostatin, C-peptide, and NKX6.1 in S6w1 SC-islets. One-way analysis of variance (ANOVA), multiple comparison using Turkey correction with 95% confidence interval. All data are presented as mean ± sem, n = 4-5 pooled differentiation batches generated using healthy, total pancreatectomy, and type-1 diabetes donor iPSC lines. *p < 0.05 and ****p < 0.0001. j Representative flow cytometry plots and quantification for enterochromaffin cell generation within the SC-β cells in S6w1 clusters. Multiple ttest statistical method is used to compare two variables with 95% confidence interval. All data are presented as mean ± sem, n = 4 pooled differentiation batches generated using healthy, total pancreatectomy, and type-1 diabetes donor iPSC lines. ****p < 0.0001. Immunohistology image show staining for SC-EC marker-SLC18A1 co-labeling with insulin. Scale bars, 50 µm. k Representative flow cytometry plots (left) to show absolute cell composition for off-target population in S6w1 SC-islets. Violin plot (right) show quantification of percentage off-target cells generated in comparison to isotype control. Two-way ANOVA with multiple comparison statistical method is used with Šidák correction and 95% confidence interval. All data are presented as mean ± sem, n = 3–4 pooled differentiation batches generated using healthy, total pancreatectomy, and type-1 diabetes donor iPSC lines. ****p < 0.0001.CC BY-NC-ND · PubMed Central
Fig. 2 In vitro functional characterization of SC-islets. a Insulin secretion response to dynamic perifusion with 2.8 mM (G3), 16.7 mM (G17) glucose, and 30 mM KCl. Secretion tracing was normalized to total DNA content (n = 3) from S6w1 (50 clusters) islets in 2 technical replicates from three independent differentiation batches—one from each healthy, total pancreatectomy, and type-1 diabetes donor iPSC lines tested. b Quantification of area under the curve from perfusion tracings between S5w2, S6w1, and donor islets. c Static insulin secretion response to varying glucose concentrations from G3 to G17 and KCl from S6w1 (30 clusters) islets in comparison to adult donor islets. Insulin levels are normalized per 1000 cells, n = 4 differentiation batches using a healthy iPSC line. Average secretion of technical replicates, n = 2, is plotted from a single representative donor islet. Two-way ANOVA with multiple comparison using Šidák correction with 95% confidence interval. All data are presented as mean ± sem, n = 4. *p < 0.05, **p < 0.001, and ****p < 0.00001. d Graphical quantification of secretion index (fold over G3) in S6w1 (30 clusters) islets upon G17 and KCl stimulation moving from 0.1 L to scale-up 0.5 L bioreactor vessel. Two-way ANOVA with multiple comparison statistical method is used with Šidák correction and 95% confidence interval. All data are presented as mean ± sem, n = 4 differentiation batches from a healthy iPSC line. *p < 0.05. e Violin plots representing average expression of genes responsible for insulin signaling and glycolysis-TCA cycle pathway. f Heatmap projection (top) of average gene expression profile in S6w1 islets generated from healthy donor iPSC line (n = 1) against immature S5w2 clusters for genes associated with glucose metabolism and secretory function. Violin plots (bottom) representing matrix of mature beta cell gene expression measured in S5w2 clusters and S6w1 islets compared to adult islets g Violin plots representing level of expression of maturation genes in comparison between immature S5w2 clusters and mature S6w1 islets from time of origin. Heat map and violin plots are generated using SR Plots bioinformatics online tool https://www.bioinformatics.com.cn/en.
Fig. 2 In vitro functional characterization of SC-islets. a Insulin secretion response to dynamic perifusion with 2.8 mM (G3), 16.7 mM (G17) glucose, and 30 mM KCl. Secretion tracing was normalized to total DNA content (n = 3) from S6w1 (50 clusters) islets in 2 technical replicates from three independent differentiation batches—one from each healthy, total pancreatectomy, and type-1 diabetes donor iPSC lines tested. b Quantification of area under the curve from perfusion tracings between S5w2, S6w1, and donor islets. c Static insulin secretion response to varying glucose concentrations from G3 to G17 and KCl from S6w1 (30 clusters) islets in comparison to adult donor islets. Insulin levels are normalized per 1000 cells, n = 4 differentiation batches using a healthy iPSC line. Average secretion of technical replicates, n = 2, is plotted from a single representative donor islet. Two-way ANOVA with multiple comparison using Šidák correction with 95% confidence interval. All data are presented as mean ± sem, n = 4. *p < 0.05, **p < 0.001, and ****p < 0.00001. d Graphical quantification of secretion index (fold over G3) in S6w1 (30 clusters) islets upon G17 and KCl stimulation moving from 0.1 L to scale-up 0.5 L bioreactor vessel. Two-way ANOVA with multiple comparison statistical method is used with Šidák correction and 95% confidence interval. All data are presented as mean ± sem, n = 4 differentiation batches from a healthy iPSC line. *p < 0.05. e Violin plots representing average expression of genes responsible for insulin signaling and glycolysis-TCA cycle pathway. f Heatmap projection (top) of average gene expression profile in S6w1 islets generated from healthy donor iPSC line (n = 1) against immature S5w2 clusters for genes associated with glucose metabolism and secretory function. Violin plots (bottom) representing matrix of mature beta cell gene expression measured in S5w2 clusters and S6w1 islets compared to adult islets g Violin plots representing level of expression of maturation genes in comparison between immature S5w2 clusters and mature S6w1 islets from time of origin. Heat map and violin plots are generated using SR Plots bioinformatics online tool https://www.bioinformatics.com.cn/en.CC BY-NC-ND · PubMed Central
Fig. 3 In vivo transplantation and maturation of SC-islets to reverse diabetes. a Schematic representation of transplantation approach and graft assessment timeline after 2, 3, and 4 months of transplantation in SCID-beige mice. Created in BioRender. Dadheech, N. (2025) https://BioRender.com/u86j668. b Random glucose monitoring after S6w1 islet transplantation to evaluate in vivo functional potential in correcting diabetes in immunodeficient SCID-beige mice. Diabetic control mice (n = 4) are marked in red, while transplanted reversed mice (n = 15; transplanted with three batches of SC-islets from healthy, total pancreatectomy, and type-1 diabetes donor iPSC lines) in green. Dotted black line represent a threshold to consider reversal and normoglycemia. Each mouse was implanted with a LinBit-insulin pellet (21 days) to control severe hyperglycemia after diabetes induction to allow for graft survival during early weeks of transplantation. Animals were monitored up to 105 days without glucose management. Mean area under the curve (top right) for each group represented glucose lowering effect from S6w1 islet transplantation for 4 months engraftment. Multiple t test statistical method is used to compare two variables with 95% confidence interval. All data are presented as mean ± sem, n = 4. ****p < 0.0001. c Kaplan-meier graph representing diabetes reversal in transplanted mice during 105 days of monitoring. T test statistical method with 95% confidence interval; n = 4–15 *p < 0.05. d Quantification of in vivo functional efficacy after impaired glucose tolerance test at 4-months post transplantation in S6w1 engrafted mice. Two-way ANOVA and multiple comparison using Šidák correction with 95% confidence interval was performed. All data are presented as mean ± sem, n = 4–10 mice, **p < 0.01 and ***p < 0.001. e In vivo glucose stimulated human c-peptide secretion from S6w1 transplanted mice at 4-months post transplantation. One-way ANOVA and multiple comparison using Turkey correction with 95% confidence interval. All data are presented as mean ± sem, n = 6, *p < 0.05. f Time dependent human c-peptide secretion from S6w1 transplanted mice at 8-, 12-, and 16-weeks post transplantation before glucose infusion at t = 0 min and after t = 60 min of 3 g/Kgbwt glucose infusion. Two-way ANOVA with average mixed effect using Turkey correction with 95% confidence interval, at multiple time points comparison. All data are presented as mean ± sem, n = 6 mice, **p < 0.01 and ****p < 0.0001. g Representative immunohistochemical images of graft harvested tissues from S6w1 transplanted mice after 16- weeks post transplantation stained for endocrine islet cells, proliferation, and vascularization markers. Scale bars, 50–200 µm. h Representative picture of whole harvested kidney with graft implanted with S6w1 islets in 16-week engrafted mice. H and E histological image displaying gross histology of graft embedded kidney and immunohistochemistry of endocrine graft region under renal subcapsular space demonstrating presence of ductal region, stained with Ck19 in a 16-weeks harvested tissue. Scale bars, 500–100 µm. i Heat map projection of islet differentiation and maturation gene clusters in 2- and 4-months engrafted mice, in comparison to S6w1 islets (average of 3 independent differentiation preps one from each healthy, total pancreatectomy, and type-1 diabetes donor) pre-transplantation. Color scale (top right) represents gene upregulation (red; >0) and downregulation (blue; <0), Graft assessment form n = 3–4 mice. SC-islet gene expression datasets are represented as an average of n = 3 independent batches from 3 donor iPSC lines. Heat map was generated using SR Plots bioinformatics online tool https://www.bioinformatics.com.cn/en. j Flow cytometry-based graft cell composition analysis as pi-chart quantification labeling as percentage of β cell, proliferating β cell, pancreatic progenitors, and endocrine progenitors. Graft cell composition is represented as heat map parts of whole representation in an entirety of harvested graft. n = 4–7 mice.
Fig. 3 In vivo transplantation and maturation of SC-islets to reverse diabetes. a Schematic representation of transplantation approach and graft assessment timeline after 2, 3, and 4 months of transplantation in SCID-beige mice. Created in BioRender. Dadheech, N. (2025) https://BioRender.com/u86j668. b Random glucose monitoring after S6w1 islet transplantation to evaluate in vivo functional potential in correcting diabetes in immunodeficient SCID-beige mice. Diabetic control mice (n = 4) are marked in red, while transplanted reversed mice (n = 15; transplanted with three batches of SC-islets from healthy, total pancreatectomy, and type-1 diabetes donor iPSC lines) in green. Dotted black line represent a threshold to consider reversal and normoglycemia. Each mouse was implanted with a LinBit-insulin pellet (21 days) to control severe hyperglycemia after diabetes induction to allow for graft survival during early weeks of transplantation. Animals were monitored up to 105 days without glucose management. Mean area under the curve (top right) for each group represented glucose lowering effect from S6w1 islet transplantation for 4 months engraftment. Multiple t test statistical method is used to compare two variables with 95% confidence interval. All data are presented as mean ± sem, n = 4. ****p < 0.0001. c Kaplan-meier graph representing diabetes reversal in transplanted mice during 105 days of monitoring. T test statistical method with 95% confidence interval; n = 4–15 *p < 0.05. d Quantification of in vivo functional efficacy after impaired glucose tolerance test at 4-months post transplantation in S6w1 engrafted mice. Two-way ANOVA and multiple comparison using Šidák correction with 95% confidence interval was performed. All data are presented as mean ± sem, n = 4–10 mice, **p < 0.01 and ***p < 0.001. e In vivo glucose stimulated human c-peptide secretion from S6w1 transplanted mice at 4-months post transplantation. One-way ANOVA and multiple comparison using Turkey correction with 95% confidence interval. All data are presented as mean ± sem, n = 6, *p < 0.05. f Time dependent human c-peptide secretion from S6w1 transplanted mice at 8-, 12-, and 16-weeks post transplantation before glucose infusion at t = 0 min and after t = 60 min of 3 g/Kgbwt glucose infusion. Two-way ANOVA with average mixed effect using Turkey correction with 95% confidence interval, at multiple time points comparison. All data are presented as mean ± sem, n = 6 mice, **p < 0.01 and ****p < 0.0001. g Representative immunohistochemical images of graft harvested tissues from S6w1 transplanted mice after 16- weeks post transplantation stained for endocrine islet cells, proliferation, and vascularization markers. Scale bars, 50–200 µm. h Representative picture of whole harvested kidney with graft implanted with S6w1 islets in 16-week engrafted mice. H and E histological image displaying gross histology of graft embedded kidney and immunohistochemistry of endocrine graft region under renal subcapsular space demonstrating presence of ductal region, stained with Ck19 in a 16-weeks harvested tissue. Scale bars, 500–100 µm. i Heat map projection of islet differentiation and maturation gene clusters in 2- and 4-months engrafted mice, in comparison to S6w1 islets (average of 3 independent differentiation preps one from each healthy, total pancreatectomy, and type-1 diabetes donor) pre-transplantation. Color scale (top right) represents gene upregulation (red; >0) and downregulation (blue; <0), Graft assessment form n = 3–4 mice. SC-islet gene expression datasets are represented as an average of n = 3 independent batches from 3 donor iPSC lines. Heat map was generated using SR Plots bioinformatics online tool https://www.bioinformatics.com.cn/en. j Flow cytometry-based graft cell composition analysis as pi-chart quantification labeling as percentage of β cell, proliferating β cell, pancreatic progenitors, and endocrine progenitors. Graft cell composition is represented as heat map parts of whole representation in an entirety of harvested graft. n = 4–7 mice.CC BY-NC-ND · PubMed Central
Fig. 4 Comparative characterization of S6w1 scRNAseq dataset with Azimuth human pancreas reference and donor islets. a Azimuth UMAP- base embedding projection to identify human pancreatic islet cell populations clustered from S6w1 scRNAseq datasets (n = 2 batches from a healthy iPSC line, 17,393 cells) after annotating with reference human pancreas dataset- Satija lab https://azimuth.hubmapconsortium.org/references/human_pancreas/ (GSE217837; n = 3 donors, 35,289 cells). b UMAP projection representing total 9 clusters identified between S6w1 SC-islets and donor adult islets using RStudio v2023.06.2 + 561 and Seurat v4.3.2. c Feature plots representing INS and GCG expression in identified clusters between S6w1 SC-islets and adult islets. d Volcano plot to show differentially expressed genes in S6w1 islet dataset in comparison to donor islets. Genes in red show upregulated genes and in cyan downregulated genes. e Violin plots to show comparative gene expression for key β cell specific markers between S6w1 islets and adult islets. Expression values on y-axis are shown as z-score normalized data for each gene. f Feature dot plots displaying representative markers for SC- β, -α, -δ, and -γ cells on individual clusters identified between islets and adult islets. Red color dots denote human donor islets and blue corresponds to S6w1 islets clusters. The size of the dots denotes counts expressing these features matched to the scale (0–100%) g Violin plots showing comparative gene expression distribution for INS and PCSK1 in individual cluster between S6w1 islets and donor islets. h Violin plots comparing gene expression levels for insulin secretion and OXPHOS associated genes between S6w1 islets and donor islets. Expression values on y-axis are shown as z-score normalized data for each gene.
Fig. 4 Comparative characterization of S6w1 scRNAseq dataset with Azimuth human pancreas reference and donor islets. a Azimuth UMAP- base embedding projection to identify human pancreatic islet cell populations clustered from S6w1 scRNAseq datasets (n = 2 batches from a healthy iPSC line, 17,393 cells) after annotating with reference human pancreas dataset- Satija lab https://azimuth.hubmapconsortium.org/references/human_pancreas/ (GSE217837; n = 3 donors, 35,289 cells). b UMAP projection representing total 9 clusters identified between S6w1 SC-islets and donor adult islets using RStudio v2023.06.2 + 561 and Seurat v4.3.2. c Feature plots representing INS and GCG expression in identified clusters between S6w1 SC-islets and adult islets. d Volcano plot to show differentially expressed genes in S6w1 islet dataset in comparison to donor islets. Genes in red show upregulated genes and in cyan downregulated genes. e Violin plots to show comparative gene expression for key β cell specific markers between S6w1 islets and adult islets. Expression values on y-axis are shown as z-score normalized data for each gene. f Feature dot plots displaying representative markers for SC- β, -α, -δ, and -γ cells on individual clusters identified between islets and adult islets. Red color dots denote human donor islets and blue corresponds to S6w1 islets clusters. The size of the dots denotes counts expressing these features matched to the scale (0–100%) g Violin plots showing comparative gene expression distribution for INS and PCSK1 in individual cluster between S6w1 islets and donor islets. h Violin plots comparing gene expression levels for insulin secretion and OXPHOS associated genes between S6w1 islets and donor islets. Expression values on y-axis are shown as z-score normalized data for each gene.CC BY-NC-ND · PubMed Central
Fig. 5 Unsupervised characterization of identified clusters from S6w1 scRNAseq dataset. a UMAP projection of combined two samples of S6w1 islets from a healthy iPSC line representing annotated islet cell population guided through islet development feature expression without reference dataset supervision. Samples were analyzed using 10X genomics software Loupe Browser v7.0.01. Clusters identified and annotated for frequency distribution as- SC- β (27%), SC-α (10%), SC-δ (1%), SC-γ (<1%), ductal (9%), SC-EC (7%), SC-polyhormonal (8%), Endothelial cells (16%), Endocrine cells (3%), non-endocrine cells (13%). b Comparative cluster identification of each sample obtained from 0.1 L and scale-up 0.5 L generated S6w1 islets to show in UMAP projection and liberality of differentiation without variability. c Feature plots of SC- β cell cluster highlighting functional β cell marker expression. Scale represents log2FC expression (0–6). Color highlight as pale yellow: downregulation and crimson red: upregulation. d Feature plots of selected endocrine clusters representing expression for islet cell differentiation and exocrine markers. Scale represents log2FC expression (0–6). Color highlight as pale yellow: downregulation and crimson red: upregulation. e Heat map plot with Manhattan neighbor distribution clustering representing differentially expressed genes associated with islet developmental pathway between identified and unsupervised annotated clusters. Scale represents log2FC (−1.5 to 1.5), where red color shows upregulation and blue corresponds to downregulation of selected gene expression. f, Violin plots comparing distribution of β and α cell makers for functional maturation gene expression between SC- β, -α, -PH, and endocrine cells. Each plot shows median gene expression distribution with interquartile range for 27–75%. g Dot plot representing differentially expressed genes for glycolysis and TCA metabolism, h Dot plot representing differentially expressed genes for insulin secretion, i Dot plot representing differentially expressed genes for exocytosis, and j Dot plot representing differentially expressed genes for disallowed genes between SC- β, -α, -δ -γ, - ε, -PH, -EC, and ductal cells. k Feature plots of endocrine clusters representing disallowed and off-target pluripotency associated genes expression. Scale represents log2FC expression (0–13). Color highlight as pale yellow: least expression and crimson red: upregulation, gray represents absence of gene expression.
Fig. 5 Unsupervised characterization of identified clusters from S6w1 scRNAseq dataset. a UMAP projection of combined two samples of S6w1 islets from a healthy iPSC line representing annotated islet cell population guided through islet development feature expression without reference dataset supervision. Samples were analyzed using 10X genomics software Loupe Browser v7.0.01. Clusters identified and annotated for frequency distribution as- SC- β (27%), SC-α (10%), SC-δ (1%), SC-γ (<1%), ductal (9%), SC-EC (7%), SC-polyhormonal (8%), Endothelial cells (16%), Endocrine cells (3%), non-endocrine cells (13%). b Comparative cluster identification of each sample obtained from 0.1 L and scale-up 0.5 L generated S6w1 islets to show in UMAP projection and liberality of differentiation without variability. c Feature plots of SC- β cell cluster highlighting functional β cell marker expression. Scale represents log2FC expression (0–6). Color highlight as pale yellow: downregulation and crimson red: upregulation. d Feature plots of selected endocrine clusters representing expression for islet cell differentiation and exocrine markers. Scale represents log2FC expression (0–6). Color highlight as pale yellow: downregulation and crimson red: upregulation. e Heat map plot with Manhattan neighbor distribution clustering representing differentially expressed genes associated with islet developmental pathway between identified and unsupervised annotated clusters. Scale represents log2FC (−1.5 to 1.5), where red color shows upregulation and blue corresponds to downregulation of selected gene expression. f, Violin plots comparing distribution of β and α cell makers for functional maturation gene expression between SC- β, -α, -PH, and endocrine cells. Each plot shows median gene expression distribution with interquartile range for 27–75%. g Dot plot representing differentially expressed genes for glycolysis and TCA metabolism, h Dot plot representing differentially expressed genes for insulin secretion, i Dot plot representing differentially expressed genes for exocytosis, and j Dot plot representing differentially expressed genes for disallowed genes between SC- β, -α, -δ -γ, - ε, -PH, -EC, and ductal cells. k Feature plots of endocrine clusters representing disallowed and off-target pluripotency associated genes expression. Scale represents log2FC expression (0–13). Color highlight as pale yellow: least expression and crimson red: upregulation, gray represents absence of gene expression.CC BY-NC-ND · PubMed Central
Fig. 6 Single cell transcriptomic comparison of SC-islets with published SC-islet datasets. a UMAP-base embedding overlay projections (Seurat v4.3.2.) indicating SC-islet transcriptomic comparison across healthy iPSC-derived S6w1 islets from Dadheech et al. (current study) with filtered and preprocessed feature matrix counts from Balboa et al. (S7w0- GSE167880) and Punn et al. (S6- GSE139535). b UMAP projection depicting cluster identification between Dadheech et al. versus Balboa et al. (0,1,2,3,4,5,6 clusters) and Dadheech et al. versus Punn et al. (0,1,2,3,4,5,6,7 clusters) datasets. c Volcano plots indicating differentially expressed genes among each cluster in comparison between Dadheech et al. versus Balboa et al. and Dadheech et al. versus Punn et al. datasets. Genes in red show upregulated genes and in cyan downregulated genes. d Volcano plots indicating differentially expressed genes after comparing β and α clusters only between Dadheech et al. versus Balboa et al. and Dadheech et al. versus Punn et al. datasets. Genes in red show upregulated genes and in cyan downregulated genes. e Feature dot plots displaying representative markers for SC- β, -α, -δ, and -γ cells on individual clusters identified between Dadheech et al. versus Balboa et al. and Dadheech et al. versus Punn et al. datasets. Red color dots denote Balboa et al. or Punn et al. datasets and blue correspond to S6w1 islet dataset. The size of the dots denotes counts expressing these features matched to the scale (0-100%). f Violin plots showing comparative gene expression distribution for representative islet population markers- INS, GCG, SST, PPY, and GHRL in S6w1 islet dataset in comparison to published Balboa et al. and Punn et al. SC-islet datasets. Expression values on y-axis are shown as z-score normalized data for each gene. g Feature plot indicating distribution of INS expression in S6w1 islet dataset versus Balboa et al. and Punn et al. datasets.
Fig. 6 Single cell transcriptomic comparison of SC-islets with published SC-islet datasets. a UMAP-base embedding overlay projections (Seurat v4.3.2.) indicating SC-islet transcriptomic comparison across healthy iPSC-derived S6w1 islets from Dadheech et al. (current study) with filtered and preprocessed feature matrix counts from Balboa et al. (S7w0- GSE167880) and Punn et al. (S6- GSE139535). b UMAP projection depicting cluster identification between Dadheech et al. versus Balboa et al. (0,1,2,3,4,5,6 clusters) and Dadheech et al. versus Punn et al. (0,1,2,3,4,5,6,7 clusters) datasets. c Volcano plots indicating differentially expressed genes among each cluster in comparison between Dadheech et al. versus Balboa et al. and Dadheech et al. versus Punn et al. datasets. Genes in red show upregulated genes and in cyan downregulated genes. d Volcano plots indicating differentially expressed genes after comparing β and α clusters only between Dadheech et al. versus Balboa et al. and Dadheech et al. versus Punn et al. datasets. Genes in red show upregulated genes and in cyan downregulated genes. e Feature dot plots displaying representative markers for SC- β, -α, -δ, and -γ cells on individual clusters identified between Dadheech et al. versus Balboa et al. and Dadheech et al. versus Punn et al. datasets. Red color dots denote Balboa et al. or Punn et al. datasets and blue correspond to S6w1 islet dataset. The size of the dots denotes counts expressing these features matched to the scale (0-100%). f Violin plots showing comparative gene expression distribution for representative islet population markers- INS, GCG, SST, PPY, and GHRL in S6w1 islet dataset in comparison to published Balboa et al. and Punn et al. SC-islet datasets. Expression values on y-axis are shown as z-score normalized data for each gene. g Feature plot indicating distribution of INS expression in S6w1 islet dataset versus Balboa et al. and Punn et al. datasets.CC BY-NC-ND · PubMed Central
Fig. 7 Dimensionality reductional visualization for cellular heterogeneity in pancreatic progenitor and SC-islets. a Experimental overview of single cells flow cytometry and dimensionality reductional analysis in S4 cells and S6 islets generated from healthy, total pancreatectomy, and type-1 diabetes donor iPSC lines. Created in BioRender. Dadheech, N. (2025) https://BioRender.com/u86j668. b viSNE visualization of 50,000 stage-4 progenitor cells for PDX1, NKX6.1, and CHGA markers against undifferentiated control. Color gradient represents the marker expression density in each cell from high (red) to low (blue) distributed in a viSNE islands. Immunohistochemistry of S4 cluster indicating staining for PDX1- (green), NKX6.1, and GP2 (red). Scale bars, 50 µm. c Self-organizing map (FlowSOM) dimensionality reductional visualization of S4 pancreatic progenitor cells for PDX1, NKX6.1, GP2 markers against undifferentiated control. Color gradient represents the density of marker expression density in each cell from high (red) to low (blue) to show heterogeneity in endocrine lineage trajectory. d viSNE visualization of 50,000 S6w1 cells for CPPT, ISL1, NKX6.1 and CHGA against undifferentiated control. Color scale represents the marker expression density in each cell from high (red) to low (blue) distributed in a viSNE islands. Immunohistochemistry of S6w1 cluster indicating staining for CPPT- (green), NKX6.1, and ISL1 (red). Scale bars, 50 µm. e Self-organizing map (FlowSOM) dimensionality reductional visualization of S6w1 islet cells for CPPT, ISL1, and NKX6.1 markers against adult islets as control. Color gradient represents the density of marker expression density in each cell from high (red) to low (blue) to show heterogeneity in endocrine lineage trajectory. Single cell flow cytometry datasets were analyzed using Cytobank Premium software v10.6 https://premium.cytobank.org/cytobank/.
Fig. 7 Dimensionality reductional visualization for cellular heterogeneity in pancreatic progenitor and SC-islets. a Experimental overview of single cells flow cytometry and dimensionality reductional analysis in S4 cells and S6 islets generated from healthy, total pancreatectomy, and type-1 diabetes donor iPSC lines. Created in BioRender. Dadheech, N. (2025) https://BioRender.com/u86j668. b viSNE visualization of 50,000 stage-4 progenitor cells for PDX1, NKX6.1, and CHGA markers against undifferentiated control. Color gradient represents the marker expression density in each cell from high (red) to low (blue) distributed in a viSNE islands. Immunohistochemistry of S4 cluster indicating staining for PDX1- (green), NKX6.1, and GP2 (red). Scale bars, 50 µm. c Self-organizing map (FlowSOM) dimensionality reductional visualization of S4 pancreatic progenitor cells for PDX1, NKX6.1, GP2 markers against undifferentiated control. Color gradient represents the density of marker expression density in each cell from high (red) to low (blue) to show heterogeneity in endocrine lineage trajectory. d viSNE visualization of 50,000 S6w1 cells for CPPT, ISL1, NKX6.1 and CHGA against undifferentiated control. Color scale represents the marker expression density in each cell from high (red) to low (blue) distributed in a viSNE islands. Immunohistochemistry of S6w1 cluster indicating staining for CPPT- (green), NKX6.1, and ISL1 (red). Scale bars, 50 µm. e Self-organizing map (FlowSOM) dimensionality reductional visualization of S6w1 islet cells for CPPT, ISL1, and NKX6.1 markers against adult islets as control. Color gradient represents the density of marker expression density in each cell from high (red) to low (blue) to show heterogeneity in endocrine lineage trajectory. Single cell flow cytometry datasets were analyzed using Cytobank Premium software v10.6 https://premium.cytobank.org/cytobank/.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

0 Valid · 0 Not valid · 40 Not checked · 208 Own results and interpretations

114 more claims

Create a free account to see all 248 claims and to verify the 73 references still open.

See all claims — free account
  • It may state two separate claims as one. 104
  • Probably not a substantial claim. 37
  • The quote only partly states this claim. 2

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

5 of 5

Citations

Cites

Show all 72 references

Cited by

Still being checked.

Metadata

Authors
Dadheech, N., Bermúdez de León, M., Czarnecka, Z., Cuesta-Gomez, N., Jasra, I. T., Pawlick, R., Marfil-Garza, B., Sapkota, S., Verhoeff, K., Razavy, H., Anwar, P., Singh, A., Ray, N., O’ Gorman, D., Jickling, G., Lyon, J., MacDonald, P., & Shapiro, A. M. J.
Affiliations
University of Alberta (CA)
Corresponding author
  • Dadheech, Nidheesh
  • Shapiro, A. M. James
Venue
npj Regenerative Medicine
Published
2025-05-29
Volume
10
Issue
1
Pages
24-24
ISSN
2057-3995 (ISSN-L)
OpenAlex
W4410851544
Cited by
23
References
72
Citations by year
2026: 20 · 2025: 3
FWCI
11.66
Type
journal article
Language
en
Open access
Licence
Locations
  • npj Regenerative Medicine (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Juvenile Diabetes Research Foundation Canada
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
Keywords
human induced pluripotent stem cells, stem cell-derived islets, vertical-wheel bioreactor, bioreactor scale-up, beta cell differentiation, glucose-dependent insulin secretion, islet transplantation, streptozotocin-induced diabetes, islet graft function, islet transcriptome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-16, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-16 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Scale up manufacturing approach for production of human induced pluripotent stem cell-derived islets using Vertical Wheel® bioreactors. https://app.cochat.ai/papers/10.1038/s41536-025-00409-y
The paper
Dadheech, N., Bermúdez de León, M., Czarnecka, Z., Cuesta-Gomez, N., Jasra, I. T., Pawlick, R., Marfil-Garza, B., Sapkota, S., Verhoeff, K., Razavy, H., Anwar, P., Singh, A., Ray, N., O’ Gorman, D., Jickling, G., Lyon, J., MacDonald, P., & Shapiro, A. M. J. (2025). Scale up manufacturing approach for production of human induced pluripotent stem cell-derived islets using Vertical Wheel® bioreactors. npj Regenerative Medicine. https://doi.org/10.1038/s41536-025-00409-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.